← Back to headlines
Gilead Sciences Acquires Ouro Medicines, Partners with Galapagos
Gilead Sciences has announced its acquisition of Ouro Medicines and a subsequent collaboration with Galapagos on the newly purchased assets, as reported by the Wall Street Journal.
23 Mar, 23:35 — 23 Mar, 23:35
Sources
Showing 1 of 1 sources
%2CxPosition%3D.5%2CyPosition%3D.5%3BResize%3D(1200%2C675)%26impolicy%3Dmedium&w=828&q=75&output=webp&default=1)
